Richer C - Search Results

1

Early and late haemodynamic and morphological effects of angiotensin II subtype 1 receptor blockade during genetic hypertension development.

Vacher E, Fornes P, Richer C, Bruneval P, Nisato D, Giudicelli JF. Vacher E, et al. Among authors: richer c. J Hypertens. 1995 Jun;13(6):675-82. doi: 10.1097/00004872-199506000-00015. J Hypertens. 1995. PMID: 7594426

2

Effects of angiotensin II type 1 receptor blockade in ApoE-deficient mice with post-ischemic heart failure.

Pons S, Hagège A, Fornes P, Gervais M, Giudicelli JF, Richer C. Pons S, et al. Among authors: richer c. J Cardiovasc Pharmacol. 2003 Jul;42(1):17-23. doi: 10.1097/00005344-200307000-00003. J Cardiovasc Pharmacol. 2003. PMID: 12827021

3

Use of ultrasonic and microsphere techniques to evaluate regional aspects of vasodilator therapy in myocardial ischaemia, arterial hypertension and heart failure.

Giudicelli JF, Berdeaux A, Richer C, Thuillez C. Giudicelli JF, et al. Among authors: richer c. J Hypertens Suppl. 1992 Jul;10(5):S29-36. J Hypertens Suppl. 1992. PMID: 1403230

4

Hemodynamic and morphological effects of quinapril during genetic hypertension development.

Richer C, Mulder P, Fornes P, Richard V, Camilleri JP, Giudicelli JF. Richer C, et al. J Cardiovasc Pharmacol. 1991 Oct;18(4):631-42. doi: 10.1097/00005344-199110000-00021. J Cardiovasc Pharmacol. 1991. PMID: 1724542

5

Angiotensin converting enzyme inhibition. Systemic and regional hemodynamics in rats and humans.

Giudicelli JF, Richer C, Richard C, Thuillez C. Giudicelli JF, et al. Among authors: richer c. Am J Hypertens. 1991 Mar;4(3 Pt 2):258S-262S. Am J Hypertens. 1991. PMID: 2043315

6

Sympathoinhibitory effects of losartan in spontaneously hypertensive rats.

Moreau N, Richer C, Vincent MP, Giudicelli JF. Moreau N, et al. Among authors: richer c. J Cardiovasc Pharmacol. 1993 Jul;22(1):126-34. doi: 10.1097/00005344-199307000-00020. J Cardiovasc Pharmacol. 1993. PMID: 7690084

7

Losartan's protective effects in stroke-prone spontaneously hypertensive rats persist durably after treatment withdrawal.

Fornes P, Richer C, Vacher E, Bruneval P, Giudicelli JF. Fornes P, et al. Among authors: richer c. J Cardiovasc Pharmacol. 1993 Aug;22(2):305-13. doi: 10.1097/00005344-199308000-00021. J Cardiovasc Pharmacol. 1993. PMID: 7692174

8

[Interaction between SR 47436, a new angiotensin II antagonist and sympathetic nervous system in pithed SHR rats].

Moreau N, Richer C, Vincent MP, Giudicelli JF. Moreau N, et al. Among authors: richer c. Arch Mal Coeur Vaiss. 1993 Aug;86(8):1269-74. Arch Mal Coeur Vaiss. 1993. PMID: 8129542 Clinical Trial. French.

9

Trandolapril's protective effects in stroke-prone spontaneously hypertensive rats persist long after treatment withdrawal.

Richer C, Fornes P, Vacher E, Bruneval P, Giudicelli JF. Richer C, et al. Am J Cardiol. 1994 Apr 7;73(10):26C-35C. doi: 10.1016/0002-9149(94)90620-3. Am J Cardiol. 1994. PMID: 8166051

10

Quinapril prevents stroke both during and after the treatment period in stroke-prone spontaneously hypertensive rats.

Vacher E, Fornes P, Domergue V, Richer C, Bruneval P, Giudicelli JF. Vacher E, et al. Among authors: richer c. Am J Hypertens. 1993 Nov;6(11 Pt 1):951-9. doi: 10.1093/ajh/6.11.951. Am J Hypertens. 1993. PMID: 8305170

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

271 results

Search Page

Filters